Literature DB >> 32557399

The Development and Evaluation of a Patient Educational Resource for Cancer-Related Cognitive Dysfunction.

Eleenor H Abraham1,2, Bilal Khan1, Erick Ling3, Lori J Bernstein4,5.   

Abstract

Cancer patients and survivors frequently experience cognitive deficits, including problems with attention and memory. These symptoms, referred to as cancer-related cognitive dysfunction (CRCD), are associated with distress. Learning about CRCD and self-management strategies may improve functioning and quality of life in cancer survivors. This study describes the development and evaluation of a CRCD resource for cancer patients. An educational booklet was developed in accordance with multiple evidence-based guidelines for cancer patient education. Cancer patients on chemotherapy (N = 113; 34% men; median age 55, range 19-85) reviewed the booklet and self-reported CRCD knowledge before and after reading the booklet. They also gave ratings on general impressions of the booklet. Seventy-five percent of participants reported that the resource increased their self-reported CRCD knowledge. A Wilcoxon signed-rank test demonstrated that exposure to the booklet elicited a statistically significant change in self-reported knowledge (Z = - 7.13, p < 0.001). A repeated-measures ANCOVA determined that the means of self-reported CRCD knowledge were significantly different between pre- and post-exposure (F(1, 92) = 7.96, p = 0.006, η2 = 0.08). Exploratory analyses revealed that self-reported CRCD knowledge increased across all educational attainment levels from pre- to post-exposure. Ninety-one percent of participants reported that all patients undergoing cancer treatment would find this booklet helpful. Cancer patients at risk for cognitive challenges gained self-reported CRCD knowledge from the booklet, and they think this knowledge would be helpful to others. A resource that makes CRCD understandable and manageable can bridge the gap in self-rated knowledge across education levels.
© 2020. American Association for Cancer Education.

Entities:  

Keywords:  Cancer survivorship; Cancer-related brain fog; Cancer-related cognitive impairment; Chemobrain; Patient education; Symptom management

Mesh:

Year:  2022        PMID: 32557399     DOI: 10.1007/s13187-020-01793-3

Source DB:  PubMed          Journal:  J Cancer Educ        ISSN: 0885-8195            Impact factor:   2.037


  23 in total

1.  Cognitive and neurobehavioral symptoms in patients with non-metastatic prostate cancer treated with androgen deprivation therapy or observation: A mixed methods study.

Authors:  Lisa M Wu; Molly L Tanenbaum; Marcel P J M Dijkers; Ali Amidi; Simon J Hall; Frank J Penedo; Michael A Diefenbach
Journal:  Soc Sci Med       Date:  2016-03-17       Impact factor: 4.634

2.  Cognitive effects of chemotherapy in breast cancer patients: a dose-response study.

Authors:  Barbara Collins; Joyce MacKenzie; Giorgio A Tasca; Carole Scherling; Andra Smith
Journal:  Psychooncology       Date:  2012-08-30       Impact factor: 3.894

3.  Pretreatment neurocognitive function and self-reported symptoms in patients with newly diagnosed head and neck cancer compared with noncancer cohort.

Authors:  Lori J Bernstein; Gregory R Pond; Hui K Gan; Kattleya Tirona; Kelvin K Chan; Andrew Hope; John Kim; Eric X Chen; Lillian L Siu; Albiruni R Abdul Razak
Journal:  Head Neck       Date:  2018-04-17       Impact factor: 3.147

Review 4.  Cognitive impairment in breast cancer survivors treated with chemotherapy depends on control group type and cognitive domains assessed: A multilevel meta-analysis.

Authors:  Lori J Bernstein; Graham A McCreath; Zahra Komeylian; Jill B Rich
Journal:  Neurosci Biobehav Rev       Date:  2017-10-29       Impact factor: 8.989

5.  Cognitive functioning after radiotherapy or chemoradiotherapy for head-and-neck cancer.

Authors:  Hui K Gan; Lori J Bernstein; Jennifer Brown; Jolie Ringash; Mehrdad Vakilha; Lisa Wang; David Goldstein; John Kim; Andrew Hope; Brian O'Sullivan; John Waldron; Albiruni R Abdul Razak; Eric X Chen; Lillian L Siu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-08-12       Impact factor: 7.038

6.  Prevalence of perceived cognitive dysfunction in survivors of a wide range of cancers: results from the 2010 LIVESTRONG survey.

Authors:  John E Schmidt; Ellen Beckjord; Dana H Bovbjerg; Carissa A Low; Donna M Posluszny; Amy E Lowery; Mary Amanda Dew; Stephanie Nutt; Sarah R Arvey; Ruth Rechis
Journal:  J Cancer Surviv       Date:  2015-08-04       Impact factor: 4.442

7.  Cognitive Function in Patients With Colorectal Cancer Who Do and Do Not Receive Chemotherapy: A Prospective, Longitudinal, Controlled Study.

Authors:  Janette L Vardy; Haryana M Dhillon; Gregory R Pond; Sean B Rourke; Tsegaye Bekele; Corrinne Renton; Anna Dodd; Haibo Zhang; Philip Beale; Stephen Clarke; Ian F Tannock
Journal:  J Clin Oncol       Date:  2015-11-02       Impact factor: 44.544

Review 8.  Cognitive impairment associated with chemotherapy for cancer: report of a workshop.

Authors:  Ian F Tannock; Tim A Ahles; Patricia A Ganz; Frits S Van Dam
Journal:  J Clin Oncol       Date:  2004-06-01       Impact factor: 44.544

9.  Chemotherapy-related cognitive dysfunction and effects on quality of life in gynecologic cancer patients.

Authors:  Diana C Pearre; Daniela A Bota
Journal:  Expert Rev Qual Life Cancer Care       Date:  2018-02-26

Review 10.  Cancer- and cancer treatment-associated cognitive change: an update on the state of the science.

Authors:  Tim A Ahles; James C Root; Elizabeth L Ryan
Journal:  J Clin Oncol       Date:  2012-09-24       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.